192 related articles for article (PubMed ID: 10650812)
1. Analysis of 4-ABP-DNA adducts and p53 alterations in urinary bladder carcinoma.
Romano G; Garagnani L; Boninsegna A; Ferrari P; Flamini G; De Gaetani C; Sgambato A; Giovanni F; Curigliano G; Ferretti G; Cittadini A; Trentini G
Anticancer Res; 1999; 19(5C):4571-6. PubMed ID: 10650812
[TBL] [Abstract][Full Text] [Related]
2. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
3. Role of TP53 in repair of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human transitional cell carcinoma of the urinary bladder.
Torino JL; Burger MS; Reznikoff CA; Swaminathan S
Carcinogenesis; 2001 Jan; 22(1):147-54. PubMed ID: 11159753
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
5. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.
Kadlubar FF; Dooley KL; Teitel CH; Roberts DW; Benson RW; Butler MA; Bailey JR; Young JF; Skipper PW; Tannenbaum SR
Cancer Res; 1991 Aug; 51(16):4371-7. PubMed ID: 1868460
[TBL] [Abstract][Full Text] [Related]
6. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
7. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
[TBL] [Abstract][Full Text] [Related]
8. DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers.
Perera FP; Santella RM; Brenner D; Poirier MC; Munshi AA; Fischman HK; Van Ryzin J
J Natl Cancer Inst; 1987 Sep; 79(3):449-56. PubMed ID: 3114532
[TBL] [Abstract][Full Text] [Related]
9. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in T1 bladder cancer of smokers and nonsmokers.
Curigliano G; Zhang YJ; Wang LY; Flamini G; Alcini A; Ratto C; Giustacchini M; Alcini E; Cittadini A; Santella RM
Carcinogenesis; 1996 May; 17(5):911-6. PubMed ID: 8640937
[TBL] [Abstract][Full Text] [Related]
11. Influence of cigarette smoking on P53 gene mutations in bladder carcinomas.
Bernardini S; Adessi GL; Chezy E; Billerey C; Carbillet JP; Bittard H
Anticancer Res; 2001; 21(4B):3001-4. PubMed ID: 11712801
[TBL] [Abstract][Full Text] [Related]
12. Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice.
Yoon JI; Kim SI; Tommasi S; Besaratinia A
Cancer Prev Res (Phila); 2012 Feb; 5(2):299-308. PubMed ID: 22086680
[TBL] [Abstract][Full Text] [Related]
13. N-hydroxy-4-aminobiphenyl-DNA binding in human p53 gene: sequence preference and the effect of C5 cytosine methylation.
Feng Z; Hu W; Rom WN; Beland FA; Tang MS
Biochemistry; 2002 May; 41(20):6414-21. PubMed ID: 12009904
[TBL] [Abstract][Full Text] [Related]
14. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
Besaratinia A; Bates SE; Pfeifer GP
Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
[TBL] [Abstract][Full Text] [Related]
15. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of p53 mutation analysis in bladder cancer tissue and urine sediment by functional assay in yeast.
Schlichtholz B; Presler M; Matuszewski M
Carcinogenesis; 2004 Dec; 25(12):2319-23. PubMed ID: 15308588
[TBL] [Abstract][Full Text] [Related]
18. 4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene.
Feng Z; Hu W; Rom WN; Beland FA; Tang MS
Carcinogenesis; 2002 Oct; 23(10):1721-7. PubMed ID: 12376482
[TBL] [Abstract][Full Text] [Related]
19. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical quantitation of DNA adducts derived from the human bladder carcinogen 4-aminobiphenyl.
Roberts DW; Benson RW; Groopman JD; Flammang TJ; Nagle WA; Moss AJ; Kadlubar FF
Cancer Res; 1988 Nov; 48(22):6336-42. PubMed ID: 3180051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
